Search company, investor...


Founded Year



Acquired | Acquired

Total Raised


About Neocleus

Neocleus aims to provide solutions for remote access, content security, secure transactions, and authentication.

Headquarters Location

One Exchange Place Suite 1000

Jersey City, New Jersey, 07302,

United States


Missing: Neocleus's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Neocleus's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Neocleus

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neocleus is included in 1 Expert Collection, including Cybersecurity.



4,937 items

Neocleus Frequently Asked Questions (FAQ)

  • When was Neocleus founded?

    Neocleus was founded in 2006.

  • Where is Neocleus's headquarters?

    Neocleus's headquarters is located at One Exchange Place, Jersey City.

  • What is Neocleus's latest funding round?

    Neocleus's latest funding round is Acquired.

  • How much did Neocleus raise?

    Neocleus raised a total of $16.4M.

  • Who are the investors of Neocleus?

    Investors of Neocleus include Intel, Battery Ventures and Gemini Israel Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.